Browsing School of Medicine by Author "Potter, Shirley M."

Now showing items 1-4 of 4

    • Influence of stromal–epithelial interactions on breast cancer in vitro and in vivo 

      Potter, Shirley M.; Dwyer, Róisín M.; Hartmann, Marion C.; Khan, Sonja; Boyle, Marie P.; Curran, Catherine E.; Kerin, Michael J. (Springer, 2011-02-23)
      Stromal cell-secreted chemokines including CCL2 have been implicated in the primary tumor microenvironment, as mediators of tumor cell migration, proliferation, and angiogenesis. Expression of CCL2 and its principal receptor ...

    • Referral of patients to plastic surgeons following self-harm: Opportunities for suicide prevention 

      Concannon, Elizabeth Sarah; Carr, S.; Doherty, Anne M.; McInerney, Shane; Birrane, John; Kearney, Laura; Hussey, Alan J.; Potter, Shirley M.; Kelly, Jack Laurence; McInerney, Niall M. (Elsevier, 2018-11-13)
      Self-harm is a common source of referral to plastic and hand surgery services. Appropriate management of these patients is complex and includes the need for close liaison with mental health services. Self-harm is the single ...

    • Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer 

      Hartmann, Marion C.; Dwyer, Róisín M.; Costello, M.; Potter, Shirley M.; Curran, Catherine E.; Hennessy, Emer; Newell, John; Griffin, Damian G.; Kerin, Michael J. (Elsevier, 2011-06-12)
      Purpose Investigate circulating CCL5 in breast cancer patients and healthy controls, along with gene expression levels in corresponding tumour tissue and isolated primary stromal cells. Hormonal control of CCL5, and a ...

    • Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones 

      Potter, Shirley M.; Dwyer, Róisín M.; Curran, Catherine E.; Hennessy, Emer; Harrington, Kate A.; Griffin, Damian G.; Kerin, Michael J. (Springer, 2008-06-04)
      Introduction The chemokines Stromal Cell-Derived Factor-1 alpha (SDF-1 alpha/CXCL12) and Monocyte Chemotactic Protein-1 (MCP-1/CCL2) have been implicated in breast cancer progression. We recently reported elevated systemic ...